Yi Wang | Medicine | Research Excellence Award

Published on by Research Chemistry Awards

Prof. Dr. Yi Wang | Medicine | Research Excellence Award

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology | China

Prof. Dr. Yi Wang is a Professor and Principal Investigator at Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, with a strong academic foundation in respiratory medicine and translational biomedical research. His education and professional training have shaped a focused career dedicated to understanding complex lung diseases, particularly pulmonary fibrosis. With extensive experience leading independent research groups, he has made significant contributions to uncovering molecular and cellular mechanisms underlying fibrotic lung remodeling. His research interests include DNA methylation, endoplasmic reticulum stress, macrophage–fibroblast interactions, gene therapy, and targeted drug delivery systems for respiratory diseases. Prof. Wang has published more than 28 high-impact scientific articles in leading international journals such as Nature Communications and the European Respiratory Journal. His work has been recognized through prestigious honors, including the National Science Fund for Excellent Young Scholars, alongside multiple national and provincial research grants. Overall, Prof. Wang’s research advances both fundamental understanding and therapeutic innovation in pulmonary fibrosis.

Citation Metrics (Scopus)

8000

6000

4000

2000

0

Citations
7,502

Documents
111

h-index
33

View Scopus Profile

Featured Publications

Autophagy Related 5 Promotes Mitochondrial Fission and Inflammation via HSP90-HIF-1α-Mediated Glycolysis in Kidney Fibrosis
– Advanced Science, 2025
Kynurenine Acts as a Signaling Molecule to Attenuate Pulmonary Fibrosis by Enhancing the AHR-PTEN Axis
– Journal of Advanced Research, 2025
Kdm2a Inhibition in Skeletal Muscle Improves Metabolic Flexibility in Obesity
– Nature Metabolism, 2025
Effect of Roxadustat on Lowering Blood Lipids in Peritoneal Dialysis Patients with Anemia: A Multicenter Randomized Controlled Study
– Renal Failure, 2025
Correlation Between Protein-Energy Wasting and Major Adverse Cardiovascular Events in Maintenance Hemodialysis Patients
– Renal Failure, 2025

Yanpeng Li | Pharmacology | Research Excellence Award

Published on by Research Chemistry Awards

Dr. Yanpeng Li | Pharmacology | Research Excellence Award

Shenzhen University | China

Dr. Yanpeng Li is a pharmacology researcher at Shenzhen University with interdisciplinary expertise spanning pharmaceutical chemistry, immunology, and targeted drug discovery. He earned his PhD in Pharmacology from Southern Medical University and completed joint doctoral training at the Karolinska Institutet under Nobel Committee member Prof. Rikard Holmdahl, where his research centered on natural medicinal flavonoids, particularly kaempferol, in autoimmune diseases and virus immunology. Dr. Li further strengthened his international research profile through postdoctoral training in viral immunology at the Karolinska Institutet and is currently pursuing postdoctoral research at Shenzhen University, focusing on targeted therapeutic strategies for acute myeloid leukemia. His academic and professional journey reflects a strong integration of basic pharmacological mechanisms with translational drug development. Dr. Li is an active member of several professional bodies, including the Editorial Board of the International Conference on Disease Genetics and Genomics, the Clinical Rational Drug Use Committee of the Shenzhen Medical Doctor Association, and the Swedish Pharmacists’ Association. His research interests encompass natural compounds, autoimmune disorders such as rheumatoid arthritis, psoriasis, and systemic lupus erythematosus, viral immunology, acute myeloid leukemia, and precision-targeted therapies. In recognition of his academic excellence, he has received multiple scholarships and awards from institutions in China and Sweden. Overall, Dr. Li’s work contributes significantly to advancing targeted therapeutics and evidence-based pharmacological innovation.

View ORCID Profile

Featured Publications

Pengyuan Wang | Pancreatitis | Young Researcher Award

Published on by Research Chemistry Awards

Mr. Pengyuan Wang | Pancreatitis | Young Researcher Award

Department of Gastroenterology, Changhai Hospital, Naval Medical University | China

Mr. Pengyuan Wang is an accomplished biomedical researcher and clinician specializing in gastroenterology and translational pharmacology. He obtained a Bachelor’s degree in Clinical Medicine, followed by a Ph.D. in Pharmacology, and further strengthened his academic foundation through postdoctoral training in Gastroenterology. He is currently affiliated with leading clinical and research centers in China, where he integrates clinical insight with mechanistic research to address complex gastrointestinal diseases. His professional experience bridges patient-oriented practice and laboratory-based investigation, enabling a strong bench-to-bedside research approach. Mr. Wang’s primary research interest focuses on the metabolic mechanisms underlying pancreatitis, with particular emphasis on identifying key molecular pathways involved in disease initiation and progression. In parallel, he is actively engaged in drug screening and pharmacological evaluation, aiming to discover and optimize therapeutic candidates for pancreatitis and related metabolic disorders. His work contributes to improving diagnostic strategies and advancing targeted treatments in gastroenterology. Recognized for his rigorous scientific approach and interdisciplinary expertise, he has received academic acknowledgment through competitive research training and scholarly contributions. Overall, Mr. Wang’s research continues to enhance the understanding of pancreatitis pathophysiology and supports the development of innovative therapeutic interventions with significant clinical relevance.

View ORCID Profile

Featured Publications

Weikai Zhang | Drug Discovery | Research Excellence Award

Published on by Research Chemistry Awards

Dr. Weikai Zhang | Drug Discovery | Research Excellence Award

Luoyang Polytechnic, China

Dr. Weikai Zhang is a dedicated biomedical engineering researcher whose work centers on advancing single-cell technologies for improved antibody discovery and biomedical applications. He earned his PhD in Biomedical Engineering from the School of Life Science at the Beijing Institute of Technology, preceded by a Master’s degree from Henan University of Science and Technology and a Bachelor’s degree in Biotechnology from Xinyang Agricultural College. His academic journey included extensive joint master’s and doctoral research at the National Center for Nanoscience and Technology, where he investigated nanobiological effects and safety. Earlier in his career, he contributed as a technician in the Antibody Engineering Laboratory at the National Protein Science Center in Beijing, gaining foundational expertise in protein science and antibody development. Currently, he serves as a Lecturer and Deputy Director of the Key Engineering Technology Research Center for Immune Technology Biological Materials Preparation in Henan Province. His research focuses on designing and developing microfluidic chips for single-cell analysis, improving throughput and screening efficiency, and enhancing diagnostic and therapeutic antibody development. Recognized for his scientific contributions, he has received multiple honors, including youth talent awards and innovation recognitions. Dr. Zhang continues to advance impactful research in biomedical engineering and single-cell technology.

Profile: Orcid

Featured Publications

Zhang, W., Li, Q., Jia, F., Hu, Z., & Wei, Z. (2021). “A microfluidic chip for screening and sequencing of monoclonal antibody at a single-cell level.” Analytical Chemistry. https://doi.org/10.1021/acs.analchem.1c00918